Cooperative effect of TNF alpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity

被引:252
作者
Koolwijk, P [1 ]
vanErck, MGM [1 ]
deVree, WJA [1 ]
Vermeer, MA [1 ]
Weich, HA [1 ]
Hanemaaijer, R [1 ]
vanHinsbergh, VWM [1 ]
机构
[1] GBF,DEPT GENE EXPRESS,D-38124 BRAUNSCHWEIG,GERMANY
关键词
D O I
10.1083/jcb.132.6.1177
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In angiogenesis associated with tissue repair and disease, fibrin and inflammatory mediators are often involved. We have used three-dimensional fibrin matrices to investigate the humoral requirements of human microvascular endothelial cells (hMVEC) to form capillary-like tubular structures. bFGF and VEGF(165) were unable to induce tubular structures by themselves. Simultaneous addition of one or both of these factors with TNF alpha. induced outgrowth of tubules, the effect being the strongest when bFGF, VEGF(165), and TNF alpha were added simultaneously, Exogenously added u-PA, but not its nonproteolytic amino-terminal fragment, could replace TNF alpha, suggesting that TNF alpha-induced u-PA synthesis was involved. Soluble u-PA receptor (u-PAR) or antibodies that inhibited u-PA activity prevented the formation of tubular structures by 59-99%. epsilon-ACA and trasylol which inhibit the formation and activity of plasmin reduced the extent of tube formation by 71-95%. TNF alpha or u-PA did not induce tubular structures without additional growth factors. bFGF and VEGF(165) enhanced of the u-PAR by 72 and 46%, but TNF alpha itself also increased u-PAR in hMVEC by 30%. Induction of mitogenesis was not the major contribution of bFGF and VEGF(165) because the cell number did not change significantly in the presence of TNF alpha, and tyrphostin A47, which inhibited mitosis completely, reduced the formation of tubular structures only by 28-36%. These data show that induction of cell-bound u-PA activity by the cytokine TNF alpha is required in addition to the angiogenic factors VEGF(165) and/or bFGF to induce in vitro formation of capillary-like structures by hMVEC in fibrin matrices. These data may provide insight in the mechanism of angiogenesis as occurs in pathological conditions.
引用
收藏
页码:1177 / 1188
页数:12
相关论文
共 64 条
[1]   INVIVO PATTERNS OF EXPRESSION OF UROKINASE AND ITS INHIBITOR PAI-1 SUGGEST A CONCERTED ROLE IN REGULATING PHYSIOLOGICAL ANGIOGENESIS [J].
BACHARACH, E ;
ITIN, A ;
KESHET, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10686-10690
[2]  
BARNATHAN ES, 1990, BLOOD, V76, P1795
[3]   ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULES IN HUMAN-DISEASE [J].
BEVILACQUA, MP ;
NELSON, RM ;
MANNORI, G ;
CECCONI, O .
ANNUAL REVIEW OF MEDICINE, 1994, 45 :361-378
[4]   INTERACTION OF VASCULOTROPIN VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR WITH HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS - BINDING, INTERNALIZATION, DEGRADATION, AND BIOLOGICAL EFFECTS [J].
BIKFALVI, A ;
SAUZEAU, C ;
MOUKADIRI, H ;
MACLOUF, J ;
BUSSO, N ;
BRYCKAERT, M ;
PLOUET, J ;
TOBELEM, G .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 149 (01) :50-59
[5]   THE UROKINASE RECEPTOR - STRUCTURE, REGULATION AND INHIBITOR-MEDIATED INTERNALIZATION [J].
BLASI, F ;
CONESE, M ;
MOLLER, LB ;
PEDERSEN, N ;
CAVALLARO, U ;
CUBELLIS, MV ;
FAZIOLI, F ;
HERNANDEZMARRERO, L ;
LIMONGI, P ;
MUNOZCANOVES, P ;
RESNATI, M ;
RIITTINEN, L ;
SIDENIUS, N ;
SORAVIA, E ;
SORIA, MR ;
STOPPELLI, MP ;
TALARICO, D ;
TEESALU, T ;
VALCAMONICA, S .
FIBRINOLYSIS, 1994, 8 :182-188
[6]   PRODUCTION AND CHARACTERIZATION OF A SET OF MONOCLONAL-ANTIBODIES AGAINST TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) [J].
BOS, R ;
SIEGEL, K ;
OTTER, M ;
NIEUWENHUIZEN, W .
FIBRINOLYSIS, 1992, 6 (03) :173-182
[7]  
BROADLEY KN, 1989, LAB INVEST, V61, P571
[8]   EVALUATION OF THE PLASMINOGEN/PLASMIN SYSTEM IN TRANSGENIC MICE [J].
CARMELIET, P ;
COLLEN, D .
FIBRINOLYSIS, 1994, 8 :269-276
[9]  
CAVENDER DE, 1989, AM J PATHOL, V134, P551
[10]   ANGIOGENESIS AND RHEUMATOID-ARTHRITIS - PATHOGENIC AND THERAPEUTIC IMPLICATIONS [J].
COLVILLENASH, PR ;
SCOTT, DL .
ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (07) :919-925